Global Dental Crown Removal Market Projected to Experience Steady Growth, Reaching USD 461.9 Million by 2033

The global dental crown removal market is on a promising trajectory, estimated to secure a compound annual growth rate (CAGR) of 4.6% during the forecast period. Following a valuation of USD 294.95 million in 2023, the market is projected to reach USD 461.9 million by 2033.

The majority of dental crown applications lie within restorative dentistry, where aesthetic appeal plays a crucial role. Dental crowns made of glass or ceramic are particularly favored due to their remarkable physicochemical properties, including sufficient strength, excellent aesthetics, chemical toughness, low heat conductivity, translucency, biocompatibility, and wear resistance. These characteristics make them highly attractive options for both patients and dentists.

As the demand for improved visualization of pulp morphology and tooth fractures grows, the dental crown removal sector is witnessing increased attention. This procedure is often performed for endodontic treatment or re-treatment of previously treated teeth to eliminate pathogenic elements identified through radiographic examinations, a critical step in addressing oral and dental infections.

Why Dentists Prefer Dental Crown Removal for Patients:

Dentists are committed to protecting patients’ natural teeth, often opting for dental crown removal instead of tooth extraction to enhance oral health. Several key reasons underscore the rising adoption of dental crown removal procedures:

  • Decay: If decay or infection develops beneath a dental crown, dentists may need to remove it to relieve discomfort and restore health.
  • Damage: Dental crowns that sustain damage may require removal for repair or replacement.
  • Misalignment: Patients experiencing misalignment or improper seating of crowns may necessitate removal to correct the issue.
  • Gum Disease: The prevalence of gum disease at the base of the tooth can lead to an uptick in dental crown removal, helping to prevent further oral complications.
  • Cosmetic Concerns: Evolving patient preferences for aesthetic enhancements often prompt dentists to replace existing crowns with new, improved options.

With increasing awareness of oral health and advancements in dental technologies, the dental crown removal market is poised for significant growth, ultimately enhancing patient care and satisfaction.

Key Takeaways:

  • The dental crown removal market is predicted to register a CAGR of 4.6% with a valuation of USD 461.9 million in 2033.
  • In the historical period, the market secured a CAGR of 3.5% between 2018 and 2022.
  • The United States is estimated to lead the global market by securing a share of 31.6% by 2033.
  • Germany is significantly growing the global market size by capturing a share of 7.5% during the forecast period.
  • With a share of 5%, Japan is anticipated to drive the global market during the forecast period.
  • Australia is projected to capture a share of 4.7% in the global market by 2033.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Key Player’s Performance in the Global Market:

Key players play a crucial role in the global market by developing high-quality and long-lasting dental crowns. They offer different types of dental crowns with varying price ranges to patients. They are also developing automated dental crown removal tools and related equipment widely used by healthcare professionals and dentists.

The key players are adopting various marketing tactics, including collaborations, mergers, acquisitions, partnerships, product launches, and agreements. A few of the key players are mentioned below:

  • Dentsply Sirona:The company provides a range of dental crown and dental removal tools with advanced technology. A few of these tools are carbide cutters and diamond burs.
  • Komet USA: The company is a leading supplier of dental tools and instruments in the global market. They offer a variety of dental crown removal tools to offer better treatment to patients.

Other Prominent Players in the Global Market are:

  • Integra LifeSciences Corporation
  • Artman Instruments
  • PREMIUM INSTRUMENTS
  • OdontoMed2011
  • ProDent USA
  • Wise Instruments
  • Hu-Friedy Mfg. Co., LLC
  • Medspo Instruments
  • Morrell Dental
  • Dentmark
  • Addler
  • Polident
  • Goldfinch
  • GDC
  • Dentus
  • DMG
  • Osung
  • Trust & Care
  • API
  • Dental

Recent Developments in the Global Market are:

  • In 2021, Brasseler USA launched its new diamond burs Brasseler USA Xcite. This new dental crown removal offers superior cutting options with better performance. It reduces the time of dentists and patients during the procedure.
  • In 2020, Kerr Dental launched its new product SonicFill 3 composite filling system. It offers easy-to-use, fast, reliable, and efficient methods to fill cavities.
  • In 2020, Hu-Friedy announced its newly launched Harmony Ergonomic Scalers and Curettes. It is designed to improve clinical comfort and reduce fatigue during dental procedures. The company aims to provide this product to enhance patients’ experiences.

Key Segments in the Dental Crown Removal Market

By Technique:

  • Conservative
  • Semi-Conservative
  • Destructive

By Product:

  • Manual Systems
  • Automatic Systems

By End User:

  • Hospital
  • Dental Clinics
  • Ambulatory Surgical Centres

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:           

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pet Daycare Market Booms: Valuation Set to Reach USD 8.84 Billion by 2033, Driven by Changing Lifestyles and Rising Pet Humanization

As reported by Future Market Insights, the global pet daycare market is witnessing remarkable growth, with its net worth estimated at nearly USD 4.06 billion in 2023. This represents a significant increase from USD 3.74 billion in 2022 and is projected to surge to USD 8.84 billion by 2033, reflecting a robust CAGR of 8.1% during the forecast period.

Key Factors Driving the Pet Daycare Market

  • Changing Work Patterns: Increased working hours for pet owners lead to a higher demand for reliable daycare services.
  • Rising Disposable Income: Greater financial capacity allows pet owners to invest in premium pet care services.
  • Pet Humanization Trend: Growing perception of pets as family members drives demand for high-quality care.
  • Increased Awareness of Animal Welfare: Government and organizational efforts to enhance pet health and well-being support market growth.
  • Technological Innovations: Advancements in technology, such as scheduling apps and enhanced grooming services, improve the appeal and accessibility of pet daycare.
  • Mental Health Benefits: The rising prevalence of mental health issues prompts more people to adopt pets, increasing the need for daycare services.
  • Group Play Sessions Popularity: The preference for group play sessions promotes socialization and physical activity among pets, driving demand.
  • Market Growth in Emerging Economies: Countries like China are experiencing rapid growth due to economic development and increased pet adoption rates.

Regional Insights

  • United States: Leads the global market with a share of 39.4%, driven by high pet ownership and a focus on premium services.
  • Germany: Dominates the European market at 28.3%, supported by rising consumer spending on pet wellness.
  • China: Expected to post the highest CAGR of 9.6%, fueled by rapid economic growth and increasing pet adoption rates.
  • India: Anticipated to grow significantly with a CAGR of 10.3%, reflecting rising disposable income and urbanization.
  • Japan: Contributes 5.8% to the market, with a strong cultural emphasis on pet care and grooming.
  • Australia: Holds 2.5% of the market, characterized by a growing pet ownership trend and demand for daycare services.

Competitive Landscape

Several prominent companies are implementing strategies such as collaborations, mergers, and acquisitions to strengthen their market position. Additionally, they are expanding their global footprint by opening numerous pet care facilities worldwide.

For Instance:

  • In July 2022, Dogtopia announced it may open a second San Antonio location on the city’s far Northwest side.

Key Companies Profiled

  • PACo LLC
  • Carey Pet and Home Care
  • Best Friends Pet Care Inc
  • Camp Bow Wow
  • Dogtopia
  • Preppy Pet
  • Royvon Dog Training & Hotels
  • Barkefellers
  • Country Paws Boarding
  • Puss ‘n’ Boots Boarding Cattery
  • Urban Tails Pet Resort
  • Camp Run-A-Mutt
  • Pet Station Kennels & Cattery
  • Paradise 4 Paws LLC
  • Preppy Pet Franchises Inc.
  • Country Comfort Kennels
  • PetBacker
  • PetSmart Inc.

Tap into Expertise: Discuss with Our Analyst on Email: sales@futuremarketinsights.com

Market Segmentation

By Service Type:

  • Group Play Sessions
  • Exercise
  • Poolside
  • Grooming
  • Veterinary
  • Others

By Animal Type:

  • Dogs
  • Cats
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Over-the-Counter Veterinary Drugs Market Poised for Remarkable Growth: Projected CAGR of 7.9% Through 2033

The global over-the-counter (OTC) veterinary drugs market is on the brink of substantial expansion, forecasting a Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2033. According to the latest market analysis, the industry is set to achieve a significant market share of USD 19.01 billion by 2033, a notable increase from its estimated value of USD 8.8 billion in 2023.

This impressive growth trajectory is primarily driven by the surge in pet ownership, particularly of dogs and cats, which has intensified in the post-pandemic era. As pets increasingly become integral members of households, there is a growing emphasis on their health, nutrition, and overall well-being. This shift in pet ownership dynamics is significantly propelling the demand for OTC veterinary drugs, celebrated for their convenience and accessibility.

A key contributor to this market growth is the rising preference among pet owners for easily accessible health solutions for their pets. The ability to procure OTC veterinary drugs without the need for a veterinarian’s prescription has resulted in a notable increase in their use. This trend is further bolstered by recent regulatory changes that have expanded the availability of OTC veterinary drugs, promoting greater consumer access to a diverse array of veterinary products. These evolving legal frameworks simplify the procurement process, enhancing the quality of pet care and providing peace of mind to pet owners.

As the OTC veterinary drugs market continues to evolve, it is well-positioned to flourish, offering pet owners convenient options for maintaining their pets’ health and well-being. With an increasing number of households embracing the benefits of OTC solutions, the future of this market looks promising.

Key Takeaways:

  • The United States market leads the over-the-counter (OTC) veterinary drugs market in terms of market share in North America. The United States region held a market share of 25.6% by 2022. The growth in this region is attributed to higher pet adoption and government efforts. North America dominates the market as it held a 35% global share in 2022.
  • Germany’s over-the-counter (OTC) veterinary drugs market is another significant market in the European region. The market held a market share of 7.9% in 2022. The growth is attributed to the presence of the major OTC veterinary drug producers. Europe held a global share of 32% in 2022.
  • The Indian over-the-counter (OTC) veterinary drugs market thrives at a CAGR of 8.3% during the forecast period. The booming growth rate is attributed to the increasing pet adoption and humanization along with the increasing number of OTC veterinary drug producers in the region.
  • The oral form segment leads the dosage form type segment as it held a market share of 76.40% in 2022. The growth is attributed to lower pain unlike injections, higher effectiveness, and affordability.
  • Based on the sales channel type, the online pharmacies segment leads as it held a market share of 40% in 2022. The growth is attributed to easy shipping and higher availability.

Access the Full Report: Find Detailed Analysis on the Over-The-Counter (OTC) Veterinary Drugs Market

Competitive Landscape:

The key vendors work on a smaller number of side effects, enhanced supply chain, and higher affordability.  Companies also collaborate to expand their supply chain. Key competitors and also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

Recent Market Development:

  • Boehringer Ingelheim has introduced new products such as aftopor/aftovaxpur/aftovax, Arti-Cell FORTE, Aservo EquiHaler, and Bovela. and dairy cattle.
  • Phibro Animal Health Corporation has revisited their OTC veterinary drugs for swine, beef cattle.

Key Players:

  • Zoetis
  • Boehringer Ingelheim
  • Virbac S.A.
  • Hester Biosciences Ltd.
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Santé Animale
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Kyoritsu Seiyaku Corporation
  • AlphaVet Animal Health Ltd.
  • AdvaCare Pharma
  • Alphafacts Health Solution
  • Bimeda Animal Health Inc.

Key Segments Covered:

By Drug Class:

  • NSAIDs
  • Antihistamines
  • Decongestants & Bronchodilators
  • Antibacterial
  • H2 Receptor Antagonists
  • Nutrients & Supplements
  • Glucocorticoids
  • Lubricant eye drops & artificial tears
  • Anti-parasitic
  • Antidiarrheal agents
  • Others

By Product Form:

  • Oral
  • Injectable
  • Topical
  • Others

By Sales Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Hypermarkets & Supermarkets
  • Online Pharmacies
  • Veterinary Shops

Key Regions Covered:

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

USA Animal Model Market Reaches USD 976.1 Million in 2023: Projected Growth to USD 1,487.9 Million by 2033

The USA animal model market has achieved a remarkable valuation of approximately USD 976.1 million in 2023, marking a significant milestone in biomedical research and development. A comprehensive study by Future Market Insights underscores the increasing demand for animal models in the USA, which is poised for robust growth with an anticipated Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2033.

The forecasts from this extensive research indicate a surge in demand for animal models, projecting the market to reach an impressive USD 1,487.9 million by 2033. This growth highlights the indispensable role of animal models across various research domains, significantly contributing to scientific advancements and innovative breakthroughs.

Among the species utilized in research, mice have emerged as the dominant choice in the USA market, commanding a substantial share of over 61.03% in 2022. Their genetic proximity to humans and versatility make them invaluable assets in preclinical trials and biomedical studies, leading to their widespread adoption across research laboratories.

As the animal model market continues to expand, its contributions to advancing biomedical research and fostering innovation remain pivotal. This promising growth trajectory underscores the vital importance of animal models in driving scientific progress and enhancing the development of new therapies and treatments.

Key Takeaways from the USA Animal Model Market Study Report:

  • Back in the year 2017, the demand for animal models in the United States, in terms of value, was nearly 818.7 million.
  • Over the next ten years, the animal model market in the United States is projected to witness an absolute growth of USD 540.6 million.
  • Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
  • Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around USD 352.5 million in 2022, which was figured out to be 37.21% of the market.

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Landscape for the USA Animal Model Market Players:

Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of animal models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.

Recent Developments by the Animal Model Industries based in the USA:

  • The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
  • Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.

Key Companies Profiled:

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation).
  • Harbour Biomed
  • Sinclair BioResources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc

Key Segments Covered by USA Animal Model Industry Survey Report:

By Species:

  • Mice
  • Rats
  • Fish
  • Birds
  • Cattles
  • Pigs
  • Amphibians
  • Guinea Pigs
  • Dogs
  • Cats
  • Rabbits
  • Monkeys
  • Sheep
  • Hamsters
  • Other Animals

By Technology:

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Microinjection
  • Nuclear Transfer
  • Other Technologies

By Application:

  • Research & Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD or NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Micro-biome
    • Other Research and Developments
  • Production and Quality Control
  • Academics
  • Preclinical Applications
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD/NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Micro-biome
    • Other Preclinical Applications
  • Other Applications

By Use:

  • Human
  • Veterinary

By End-user Verticals:

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Other Companies
  • Organizations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CRO)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Fecal Pancreatic Elastase Testing Market Set to reach USD 31,842.3 Million by 2033, Highlighting Urgent Need for Enhanced Diagnosis and Treatment of Pancreatic Cancer | FMI

The global fecal pancreatic elastase testing market is poised for significant growth, projected to increase from USD 15,306.7 million in 2023 to USD 31,842.3 million by 2033, representing a robust 7.6% CAGR over the next decade. This growth underscores the urgent need for advancements in the diagnosis and treatment of pancreatic cancer, a leading cause of cancer-related deaths, particularly among young women.

Despite improvements in some areas of oncology, pancreatic cancer remains notoriously difficult to diagnose and treat. The overall diagnosis and prognosis rates have stagnated over the years, presenting a critical challenge for healthcare professionals. However, the market is witnessing numerous opportunities for progress, especially with the emergence of new drug regimens and combinations that have the potential to extend the survival of 80% of patients.

Factors contributing to the increasing prevalence of pancreatic cancer include obesity and a sedentary lifestyle. Nutritional habits, such as high fat intake and low vegetable consumption, along with the regular consumption of red and processed meats, are further driving this trend. As awareness of these dietary influences grows, the demand for effective diagnostic tools and therapeutic solutions is set to rise.

The fecal pancreatic elastase test is vital for diagnosing pancreatic insufficiency, allowing healthcare providers to tailor treatment strategies to individual patient needs. With advancements in surgical therapies, chemotherapy, and radiation therapy, the capabilities of healthcare personnel are also improving, providing new avenues to enhance patient outcomes.

As the fecal pancreatic elastase testing market evolves, stakeholders are encouraged to invest in research and development, technological innovations, and educational initiatives to better equip healthcare providers in their fight against pancreatic cancer.

“With increasing prevalence of chronic pancreatitis, the fecal pancreatic elastase testing market is expected to witness an advancement over the forecast period,” says an analyst of Future Market Insights.

The demand for fecal pancreatic esterase testing can be limited by several variables, including:

  1. Clinical Awareness: Limited awareness among healthcare providers about the benefits and indications for fecal pancreatic esterase testing may lead to underutilization.
  2. Diagnostic Alternatives: The availability of alternative diagnostic tests, such as imaging studies (e.g., CT scans, MRI) or other laboratory tests (e.g., serum pancreatic enzyme levels), may reduce the demand for this specific test.
  3. Cost Factors: The price of fecal pancreatic esterase testing, including patient out-of-pocket expenses and insurance coverage, can influence demand. If the test is expensive or not covered by insurance, fewer patients may opt for it.
  4. Patient Population: The prevalence of conditions that warrant fecal pancreatic esterase testing (e.g., chronic pancreatitis, cystic fibrosis) within a specific patient population can impact demand. In populations with a lower incidence of these conditions, demand may be limited.
  5. Test Accessibility: Availability of the test in certain geographic regions or healthcare settings can affect demand. If the test is not readily accessible or requires referral to specialized laboratories, it may deter usage.
  6. Regulatory and Reimbursement Policies: Changes in healthcare policies, reimbursement rates, and regulatory guidelines can significantly impact the demand for diagnostic testing. If testing is not prioritized or reimbursed, it may lead to reduced demand.
  7. Patient Preference and Compliance: Patients may be hesitant to undergo testing due to discomfort or the perception of invasiveness, leading to lower demand.
  8. Emerging Technologies: The development of newer, more effective diagnostic methods may overshadow fecal pancreatic esterase testing, affecting its demand in the market.
  9. Educational Gaps: A lack of education regarding the importance of early detection of pancreatic insufficiency may lead to fewer referrals for testing.
  10. Socioeconomic Factors: Socioeconomic status may influence a patient’s ability to seek medical care, access testing, and follow through with recommended diagnostic procedures.

Addressing these limitations through education, policy changes, and improved accessibility could potentially increase the demand for fecal pancreatic esterase testing in clinical practice.

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Competitive Landscape:

Manufacturers employ various key strategies to broaden their customer base, including new product launches, technological innovations, strategic partnerships, and distribution agreements among market participants.

Recent Developments:

  • In June 2020, BÜHLMANN introduced the BÜHLMANN fPELA® turbo, an innovative turbidimetric immunoassay designed to expedite the detection of human pancreatic elastase. This product has received CE certification.
  • Additionally, in May 2020, Vitassay, a developer and distributor of diagnostic tests, launched a quantitative turbidimetric test for detecting human pancreatic elastase E1 in solid stool samples.

Some Key Companies are as follows:

  • Laboratory Corporation of America® Holdings
  • DiaSorin
  • ScheBo Biotech AG
  • Immundiagnostik AG
  • Invivo Healthcare
  • DRG Instruments GMBH
  • Verisana Laboratories
  • BÜHLMANN Laboratories AG
  • CerTest Biotec S.L.
  • R-Biopharm AG
  • American Laboratory Products Company, Ltd.
  • Vitassay Healthcare, S.L.U.

Key Market Segments Covered in Fecal pancreatic elastase testing Industry Research

By Product:

  • Fecal Pancreatic Elastase ELISA Kits
  • Rapid Fecal Pancreatic Elastase Kits

By Indication:

  • Chronic Pancreatitis
  • Type 1 Diabetes
  • Cystic Fibrosis
  • Others

By End-User:

  • Hospitals
  • Diagnostics Laboratories
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:           

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Calprotectin Testing Market Soars to New Heights: Projected to Reach USD 360.2 Billion by 2033 with a Steady CAGR of 6% | FMI

The global calprotectin testing market, valued at USD 201.1 billion in 2023, is on a trajectory to nearly double, projected to reach an impressive USD 360.2 billion by 2033. With a compound annual growth rate (CAGR) of 6% over the forecast period, this surge underscores the essential role of calprotectin testing in modern healthcare, driven by an increased demand for early detection of gastrointestinal disorders.

Calprotectin testing has emerged as a fundamental diagnostic tool, particularly for its efficacy in identifying gastrointestinal conditions early on. As the prevalence of gastrointestinal disorders rises, so does the need for accurate, preventive healthcare solutions. Calprotectin testing meets this need, allowing healthcare providers to identify issues proactively, benefiting both patient outcomes and the efficiency of healthcare systems worldwide.

The current growth trend in the calprotectin testing market aligns with a larger transformation in diagnostic healthcare: the shift towards early detection and preventive care. The value placed on timely diagnoses is motivating patients and providers alike to adopt calprotectin testing, paving the way for advancements in gastrointestinal diagnostics and treatment planning.

With its reliable accuracy and relevance, calprotectin testing is set to play a pivotal role in the future of healthcare diagnostics. As awareness and adoption continue to expand, the market is positioned for sustained growth in the coming decade, further establishing calprotectin testing as a cornerstone of early diagnostic practices across the healthcare sector.

Recent Trends in the Global Calprotectin Testing Market:

The several notable trends in the global market are as follows:

  • There is rising demand for non-invasive diagnostic devices by healthcare providers and patients to produce quick and accurate results.
  • The prevalence of inflammatory bowel disease is growing rapidly. Therefore, the demand for calprotectin testing is increasing to monitor patients’ chronic health.
  • The innovation of advanced technology devices is more reliable and tract patients’ health accurately.
  • Adopting automation in calprotectin testing reduces error risk, detects efficiently, and increases productivity.

Surge in Market Needs: Discover Comprehensive Analysis and Insights in Our Detailed Report!

Key Takeaways:

  • The calprotectin testing market is securing a valuation of USD 360.2 billion with a CAGR of 6% by 2033.
  • The United States is anticipated to lead the global market by registering a share of 25.7% by 2033.
  • Japan is anticipated to register a share of 3.1% in the global market during the forecast period.
  • In the historic period, the market captured a CAGR of 5.3% between 2018 and 2022.

Key Players are Executing Plans to Rise the Market Size:

The key players are executing various plans to upsurge the global market are:

  • New Product Launches: key players are developing user-friendly, sustainable, and accurate testing devices in the market. They are launching these testing tools to satisfy patients’ requirements.
  • Collaboration: Key companies collaborate with stakeholders, research organizations, and hospitals to enhance product quality. These collaborations help them to reach relevant customers and increase sales.
  • Promotions and Marketing: Key players invest in promotional and marketing to expand their business and brand value. They promote their products on social media and educate patients about the benefits of their products.

These are a few strategies key players adopt to increase the market size:

  • Actim Oy
  • Calpro AS
  • BÜHLMANN Laboratories AG
  • EagleBio
  • CerTest Biotec S.L.
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Boditech Med Inc.
  • Biohit Oyj
  • American Laboratory Products Company, Ltd.
  • DIAsource ImmunoAssays S.A
  • R-Biopharm AG.

Recent Developments in the Global Market are:

  • In 2020, Biohit Oyj launched its new product Calprotectin ELISA kit. It is designed to collect human samples to monitor inflammatory bowel disease.
  • In 2021, Techlab Inc launched Enteric BioFire FilmArray Panel to detect gastrointestinal infections.
  • In 2021, EKF Diagnostics launched its point-of-care device to measure calprotectin. This device provides accurate and fast results to monitor patients’ diseases.

Calprotectin Testing Market by Category:

By Test Kits:

  • Calprotectin ELISA Test Kits
  • Calprotectin Rapid Testing Kits

By Sample:

  • Stool, Blood Serum/Plasma
  • Other Biological Samples

By Indication:

  • Irritable Bowel Syndrome
  • Ulcerative Colitis
  • Crohn’s Disease
  • Colorectal Cancer

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics

Region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Hormone Replacement Therapy (HRT) Market Forecasted to Reach USD 23.7 Billion by 2034, Driven by Increased Awareness and Government Initiatives

The global hormone replacement therapy market is set to experience significant growth, with its value projected to climb from USD 16,825.2 million in 2024 to an estimated USD 23,729.6 million by 2034. This expansion, marked by a steady compound annual growth rate (CAGR) of 3.50%, reflects a strong industry trajectory fueled by heightened awareness and supportive government policies.

A key driver behind the rising adoption of HRT is the growing awareness of hormone disorders and deficiencies through targeted efforts by organizations, social media campaigns, and influencer outreach. Notably, initiatives like those of the Child Growth Foundation are making substantial strides in improving the lives of individuals with rare growth hormone disorders. By disseminating crucial information and support to patients, caregivers, and healthcare providers, these organizations are elevating patient outcomes and building a foundation of understanding around hormone therapies.

Further supporting the expansion of the HRT market are governmental actions that reduce the financial burdens on individuals. In a recent example, the United Kingdom launched a pioneering scheme aimed at assisting women experiencing menopausal symptoms, enabling them to save on prescription charges annually. Such financial support initiatives are becoming increasingly common and are anticipated to further stimulate the demand for HRT globally.

Looking forward, major players in the HRT market are poised to focus on emerging markets with high population density. Recognizing oral ingestion as the most commonly prescribed method of administration, these companies are investing in production upgrades and targeted research to maintain and enhance their market positions. “Ongoing trends suggest that key players are likely to shift their focus to emerging economies with a high population density. By optimizing production and investing in research, these players can sustain growth and better serve these markets,” says an analyst at Future Market Insights.

As awareness continues to spread and support from governments grows, the global hormone replacement therapy market is positioned to achieve remarkable growth, benefiting millions worldwide.

Key Takeaways from the Hormone Replacement Therapy Market Report:

  • The market witnessed a CAGR of 4.1% in the historical period, in contrast to the 3.5% CAGR estimated for the forecast period.
  • The United States is projected to lead the market in North America. The United States is projected to register a CAGR of 1.6% through 2034, as per analysis by FMI analysts.
  • Within Europe, the United Kingdom and Germany are important hormone replacement therapy markets. The United Kingdom is predicted to register a CAGR of 2.3%, whereas Germany is predicted to expand at a CAGR of 2.1% through 2034.
  • Within Asia Pacific, China and India are significant markets lifting the regional market’s value over the next 10 years. India is expected to record a CAGR of 5.2%, while China is anticipated to record a CAGR of 4.5% through 2034.
  • Based on the therapy area, estrogen replacement therapy is expected to garner a market share of 38.9% in 2024.
  • Based on dosage form, the oral tablets/capsules are anticipated to acquire a value share of 43.2% in 2024.

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!

Key Steps Undertaken by Market Players to Grab Greater Share in the Market:

Leading players in the HRT market are consolidating their positions by joining partnerships. Players are also strategizing for mergers and acquisitions to increase their market share. Market participants are projected to assert product approvals to gain a broader patient base. With significant investment allocated for research and development, market players are expected to change the shape of hormone replacement therapy market in upcoming years.

Recent Developments Punctuating the HRT Market:

  • In September 2023, LifeMD, Inc. partnered with ASCEND Therapeutics US, LLC to debut an integrated direct-to-consumer telehealth model to enjoy improved access to EstroGel.
  • In April 2023, GOV.UK published on its site that from this day onward, women residing in England are expected to access hormone replacement therapy (HRT) in an affordable price range. This is expected to increase the accessibility of this therapy.

Prominent Companies in the Hormone Replacement Therapy Market are as Follows:

  • Eli Lilly and Company
  • Bayer AG
  • Noven Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Viatris, Inc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd.
  • ASCEND Therapeutics US, LLC.
  • AbbVie, Inc.
  • Others

Key Market Segments Covered in Global Hormone Replacement Therapy Market Research:

By Therapy Type:

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement
  • Dopamine Agonist
  • Somatostatin Analogues
  • Thyroid Hormone Replacement

By Route of Administration:

  • Oral Tablets/Capsules
  • Parenteral
  • Transdermal
  • Others

By Disease Type:

  • Menopause
  • Hypothyroidism
  • Male hypogonadism
  • Growth hormone deficiency
  • Hypoparathyroidism

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Healthcare Business Intelligence Market to Surge, Expected to Hit USD 8,657.9 Million by 2034- FMI Report

The global healthcare business intelligence market, currently valued at USD 3,973.3 million, is poised for significant growth, projected to reach USD 8,657.9 million by 2034 with a strong 8.10% CAGR. This growth trajectory is fueled by an expanding patient base in hospitals, clinics, and healthcare facilities, accompanied by an increasing prevalence of chronic illnesses and a surge in telehealth and remote patient monitoring services, especially among senior patients.

The ongoing expansion of research and development investments, both in developed and emerging nations, continues to propel this market. Demand is also rising as small- and medium-sized enterprises recognize the substantial benefits of healthcare business intelligence, utilizing data-driven insights to optimize patient care and streamline operations.

A pivotal factor in this market’s growth is the swift adoption of cloud-based delivery models. Healthcare providers increasingly prefer cloud-based business intelligence tools such as Salesforce CRM and patient engagement applications due to their flexibility, ease of access, and cost-effectiveness. Compared to on-premise and hybrid solutions, cloud-based models offer greater affordability and usability, facilitating higher adoption rates across healthcare organizations. This digital transformation enables healthcare systems to handle complex data and operational demands, fostering increased market growth.

Key Challenges and Regional Insights:

While growth prospects are strong, the market faces obstacles such as the high costs of research and development, limited infrastructure, and a lack of skilled professionals, particularly in developing economies. Additionally, instances of inaccurate and poorly managed data remain a concern, underlining the need for robust, precise data management solutions.

China is expected to play a significant role in market expansion, projected to grow at a remarkable CAGR of 14.6% through 2034. The country’s widespread adoption of advanced analytics tools is accelerating this growth, with clinical analytics anticipated to dominate, capturing 41.2% of the healthcare business intelligence market. This increase is driven by the growing use of data-driven clinical decision-making, underscoring a global shift toward more informed, evidence-based healthcare practices.

The future of healthcare business intelligence is bright, with cloud solutions and analytics tools leading the charge. As demand for more efficient, cost-effective, and data-centric healthcare solutions rises globally, the market is positioned for sustained growth, impacting patient outcomes and healthcare management across the board.

Key Takeaways from the Healthcare Business Intelligence Market:

  • China healthcare business intelligence market is expected to thrive at a 14.6% CAGR during the forecast period.
  • Spain is expected to thrive at a CAGR of 11.8% throughout 2034.
  • Japan is likely to ascend at a CAGR of 10.9% from during the projected period.
  • Clinical analytics is projected to hold a market share of 41.20% during the forecast period.
  • On premise is expected to hold a market share of 80% throughout 2034.

“Integration of cloud technology is forecasted to present potential opportunities for the market players during the forecast period,” says an FMI analyst.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape:

The healthcare business intelligence market is relatively competitive, with a few major players and new entrants. Product innovation and continued research and development initiatives to create improved technologies are projected to propel the market forward.

The global footprint of leading players, large product portfolios, and growing emphasis on improvements in healthcare business intelligence solutions are all influencing market growth. Leading vendors are developing mobile based business intelligence solutions that enable customers to access high quality analytic services remotely, which is boosting revenue growth. 

Recent Developments:

  • In April 2024, Oracle Corporation introduced the Autonomous Shield initiative to help healthcare clients transition to a full EHR and Cloud Infrastructure solution that reduces risk and enhances performance.
  • In March 2024, Stanford Medicine and Microsoft announced the enterprise-wide implementation of Nuance Dragon Ambient eXperience Copilot (DAX Copilot), offering conversational, ambient, and generative AI to practitioners.

Key Companies Profiled:

Microsoft; Oracle Corporation; SAP; Tableau Software Inc.; Perficient Inc.; Tibco Software Inc.; Infor Inc.; Domo Inc.; Sisense Inc.; Panorama Software Inc.

Segmentation Analysis of the Healthcare Business Intelligence Industry

By Function:

The healthcare business intelligence market is classified into clinical analytics, financial analytics and operational analytics.

By Deployment:

The healthcare business intelligence market is classified into on premise and cloud based.

By Region:

Analysis of the healthcare business intelligence market has been carried out in key countries of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Disease Resistant Mask Market Projected for Significant Growth Amid Rising Health Awareness and Demand

The global disease-resistant mask market is anticipated to surpass USD 2,332.35 million in 2023 and is projected to reach USD 3,587.56 million by 2033, demonstrating a robust growth rate of 4.40% during the forecast period. This growth is largely fueled by increasing consumer awareness about health conditions amid rising infectious disease cases.

As individuals become more conscious of their health, the demand for high-quality disease-resistant masks is growing. While popular options like N95 respirators and surgical masks remain in demand, the emergence of counterfeit brands poses challenges. Consumers are increasingly favoring masks that offer low breathing resistance, balancing comfort with necessary protection.

Healthcare professionals are particularly reliant on disease-resistant masks, as these masks help mitigate contamination risks from bacteria and other microorganisms. Additionally, the fitness industry is witnessing a surge in the adoption of these masks, reflecting a broader commitment to health and safety.

Market Dynamics

Key factors driving the disease-resistant mask market include:

  • User-Specific Needs: Increasing awareness among individuals with allergies has heightened demand for masks tailored to various shapes and sizes, providing protection against airborne particles.
  • Healthcare Improvements: As healthcare costs rise, there’s a growing need for enhanced healthcare services, further stimulating market demand.
  • Accessibility: The widespread availability of disposable masks through various distribution channels has contributed to their increased usage.
  • Government Guidelines: Preventive measures endorsed by governments mandating mask usage have reinforced the market’s growth trajectory.

Regional Insights

  • Asia Pacific: Expected to lead the market due to robust manufacturing capabilities and a growing healthcare infrastructure, particularly in China and India.
  • North America: Holding a 27% market share, the region benefits from rising pollution levels and strong public health initiatives.
  • Europe: With a 23.60% market share, Europe’s advanced healthcare industry and rising infectious disease rates are crucial to its market growth.

Key Players Operating in the Global Market:

  • Under Armour
  • Uvex
  • KOWA
  • The Gerson Company
  • DACH
  • The Yin
  • McDavid
  • Reebok
  • Athleta
  • Jjyye
  • KORAL
  • INTO THE AM
  • Zensah
  • HCMY
  • FAYBOX
  • WATTIE INK
  • ELIEL
  • Mask Culture
  • Prime Layers
  • Carbon 38

Recent Developments

  • In January 2022, Maskc launched KF94 Face mask, which is made up of four layers, a non-woven external layer, two non-woven and melt-blown central layers, and a soft inner layer that is gentle on the skin.
  • In November 2021, Health Canada approved Ezzigroup Inc.’s compostable surgical-grade face mask manufactured in Canada. These compostable masks are ASTM F-2100 certified and are available for distribution in Canada and the United States under their EzziMed brand.
  • In April 2021, Cardinal Health Inc. increased the production of gowns, and surgical and procedural masks for the North America region by expanding its production line. The company has also increased its safety needle production capacity by 15 million units.
  • In February 2020, Alpha Pro Tech Ltd. announced an increase in production of their N95 respirator masks in response to immense market demand. The company as a result has expanded its production facilities in Salt Lake City, Utah, and is likely to make additional N95 respirator masks.

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Disease Resistant Mask Market Segmentation

By Layer:

  • Single Layer
  • Double Layer
  • Triple Layer
  • Multi-layer

By Nature:

  • Reusable
  • Disposable

By Distribution Channel:

  • B2B
  • B2C
  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Sports Stores
  • Online Retail

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Solid White Films Market is Expected to Generate USD 3,848.1 Million by 2034: Future Market Insights, Inc.

The global solid white films market is poised for steady growth over the next decade, with market size estimated to be valued at USD 2,808.3 million in 2024 and projected to reach USD 3,848.1 million by 2034. According to a recent market analysis, sales of solid white films are expected to rise at a CAGR of 3.2% from 2024 to 2034. The revenue generated by solid white films in 2023 was USD 2,723.9 million, indicating steady growth in the sector.

Solid white films with a thickness range of 0.1 to 0.5 mm are a dominant choice across various industries, particularly in food, medical, cosmetics, and personal care sectors.

These films are projected to capture 45.2% of the market share in 2024 due to their optimal balance of flexibility and strength, cost-effectiveness, and compatibility with automated packaging machinery. Their lightweight nature makes them ideal for packaging a wide range of products, making them indispensable for end-use industries.

Unlock Growth Potential – Request Your Sample Now and Explore Market Opportunities!

In terms of packaging applications, multilayered packaging trays made from solid white films have gained significant traction, accounting for a 44.1% share of the market in 2024. These trays offer an effective barrier against external contaminants, ensuring product safety and preservation during storage and transportation. As demand for secure and reliable packaging solutions rises, the use of solid white films in tray manufacturing is set to expand further.

Various materials are used to manufacture solid white films, with BOPP (biaxially oriented polypropylene) emerging as the dominant material in the market. Its strength, clarity, and versatility have made BOPP a preferred choice for packaging in diverse industries, and it is expected to continue its dominance in the materials segment in the coming years.

As the demand for innovative and sustainable packaging solutions grows, solid white films are set to play a crucial role across industries. The market’s expansion reflects the increasing need for reliable, high-performance materials that meet the evolving demands of modern packaging.

Key Takeaways: Solid White Films Market

  • The global solid white films market recorded a CAGR of 2.3% between 2019 and 2023.
  • The USA market is projected to grow at a CAGR of 2.8% during the forecast period.
  • India is expected to experience a CAGR of 3.8% by 2034, leading growth in the South Asia and Pacific region.
  • China is forecasted to record the highest growth in East Asia, with a CAGR of 3.9% by 2034.
  • Trays are anticipated to account for 44.1% of the market share by packaging type by 2034.
  • The food packaging segment is projected to dominate the market, holding a 42.6% share by the end of 2034.

Competitive Landscape

Leading companies in the solid white films are creating and introducing new goods to the market. They are expanding their geographic reach and merging with other companies. Few of them are also working together to develop new products in partnerships with start-up businesses and regional brands.

Key Developments in Solid White Films Market

  • In May 2024, Uflex Limited launched “B-UUB-M” Outstanding Barrier Metallized BOPP Film for various packaging structures.
  • In December 2023, Cosmo Films introduced a new metallised electrical grade BOPP film to its product portfolio for capacitor manufacturing of multiple types of AC and DC capacitors.

Key Players in Solid White Films Market

  • Cosmo Films
  • Rowad Plastic Group
  • JPFL Films Private Limited (B.C. Jindal group)
  • Interni Film
  • Süper Film Packaging Industry Inc. (Sanko Holding)
  • ESTER INDUSTRIES LIMITED.
  • Polyplex Corporation Limited.
  • Toray Plastics (America), Inc.
  • Taghleef Industries
  • Copol International Ltd.
  • Qingdao Cloud film Packaging materials Co., Ltd.
  • Innovia Films (CCL Industries)
  • UFlex Limited
  • Nobelus
  • Kaveri Metallising & Coating Ind. Private Limited

Solid White Films Market Segmentation

By Packaging Types:

Solid white films are used in different packaging types which include trays, blister packs, pouches, and labels.

By Thickness:

Solid white films are available in multiple thickness range such as less than 0.1 mm, 0.1 to 0.5 mm, and above 0.5 mm.

By Material:

Materials such as BOPP, BOPET and CPP are some of the major materials used for making solid white films.

By End Use:

End users related to solid white films market are food packaging, pharmaceutical, cosmetics, and industrial.

By Region:

Key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, Middle East and Africa are covered.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube